CD4 and COVID-19: Analysis of circulating SARS-CoV-2-specific CD8+ and CD4+ T cells in blood samples from COVID-19 patients revealed the immunodominance pattern for M, S, and N proteins, each recognized by 100% of COVID-19 cases studied.